Efficacy of Botulinum Toxin A in Preventing Recurrence Keloids: Double Blinded Randomized Controlled Trial Study: Intraindividual Subject.

Conclusion: BTXA is not significantly better in preventing recurrence keloids when compared to corticotherapy after one and three months. However, Corticotherapy provides a significantly better outcome than BTXA at 6-month follow-up. PMID: 29911784 [PubMed - in process]
Source: Journal of the Medical Association of Thailand = Chotmaihet thangphaet - Category: General Medicine Tags: J Med Assoc Thai Source Type: research